Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sensus Healthcare (SRTS)
NASDAQ:SRTS
Holding SRTS?
Track your performance easily
SRTS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.79 - $7.18
Previous Close$6.12
Volume79.72K
Average Volume (3M)193.05K
Market Cap
$100.30M
Enterprise Value$82.03M
Total Cash (Recent Filing)$18.97M
Total Debt (Recent Filing)$698.00K
Price to Earnings (P/E)15.0
Beta2.16
Next Earnings
Nov 07, 2024EPS Estimate
-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.41
Shares Outstanding16,389,051
10 Day Avg. Volume176,095
30 Day Avg. Volume193,051
Standard Deviation0.21
R-Squared0.07
Alpha0.00970
Financial Highlights & Ratios
Price to Book (P/B)1.90
Price to Sales (P/S)2.74
Price to Cash Flow (P/CF)5.90
P/FCF Ratio5.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.26
Enterprise Value/Gross Profit5.83
Enterprise Value/Ebitda9.13
Forecast
1Y Price Target
$10.67Price Target Upside78.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Sensus Healthcare News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalyst recommends maintaining a 'Buy' rating as the company has surpassed fourth quarter revenue expectations significantly, indicating strong financial health and momentum.
Innovation And Regulatory MilestonesThe anticipation of FDA approval for the re-engineered TransDermal Infusion Systems could unlock new opportunities and drive stock value higher upon successful market entry.
Product ExpansionIntroduction of a recurring revenue model and the planned expansion into new international markets signal potential for sustained growth and diversification.
Bears Say
EarningsA significant revenue downturn is evident as the company's total revenue plummeted by 45%, which could signal underlying business challenges.
Product DemandDemand for the company's SRT systems appears to be waning, with shipments dropping significantly, indicating potential loss of market share or competitive edge.
Revenue ForecastThe company's financial performance is under scrutiny as it missed revenue projections by a large margin, falling short by over 40% and raising concerns about its market predictions.
---
Ownership Overview
27.14% Insiders
7.38% Mutual Funds
8.15% Other Institutional Investors
57.33% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRTS FAQ
What was Sensus Healthcare’s price range in the past 12 months?
Sensus Healthcare lowest stock price was $1.79 and its highest was $7.18 in the past 12 months.
What is Sensus Healthcare’s market cap?
Currently, no data Available
When is Sensus Healthcare’s upcoming earnings report date?
Sensus Healthcare’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Sensus Healthcare’s earnings last quarter?
Sensus Healthcare released its earnings results on Aug 08, 2024. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of $0.023 by $0.077.
Is Sensus Healthcare overvalued?
According to Wall Street analysts Sensus Healthcare’s price is currently Undervalued.
Does Sensus Healthcare pay dividends?
Sensus Healthcare does not currently pay dividends.
What is Sensus Healthcare’s EPS estimate?
Sensus Healthcare’s EPS estimate is -$0.01.
How many shares outstanding does Sensus Healthcare have?
Sensus Healthcare has 16,389,051 shares outstanding.
What happened to Sensus Healthcare’s price movement after its last earnings report?
Sensus Healthcare reported an EPS of $0.1 in its last earnings report, beating expectations of $0.023. Following the earnings report the stock price went up 1.429%.
Which hedge fund is a major shareholder of Sensus Healthcare?
Among the largest hedge funds holding Sensus Healthcare’s share is Sheaff Brock Investment Advisors LLC. It holds Sensus Healthcare’s shares valued at N/A.
---
Sensus Healthcare Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.67 (78.13% Upside)
$10.67 (78.13% Upside)
Blogger Sentiment
Bullish
SRTS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 40.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▲ 7.8%
Last 30 Days ▲ 7.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
124.17%
12-Months-Change
Fundamentals
Return on Equity
13.44%
Trailing 12-Months
Asset Growth
11.82%
Trailing 12-Months
Company Description
Sensus Healthcare
Sensus Healthcare, Inc. engages in the design, manufacture, and marketing of proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions. Its main product is SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
---
SRTS Earnings Call
Q2 2024
0:00 / 0:00
---
SRTS Stock 12 Month Forecast
Average Price Target
$10.67
▲(78.13% Upside)
Technical Analysis
Best Analysts Covering SRTS
1 Year
1 Year Success Rate
14/20 ratings generated profit
1 Year Average Return
+50.41%
reiterated a buy rating last month
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +50.41% per trade.
---